Study of VX-765 in Subjects With Treatment-resistant Partial Epilepsy
- Status
- COMPLETED
- Phase
- PHASE2
Clinical Trials Related to Vertex Pharmaceuticals Incorporated
Related studies linked through entity extraction aliases.
A Study to Examine the Effects of Telaprevir on the Pharmacokinetics of Cyclosporine and Tacrolimus in Healthy Adults
- Status
- COMPLETED
- Phase
- PHASE1
Study of VX-770 and Rifampin in Healthy Male Subjects
- Status
- COMPLETED
- Phase
- PHASE1
Safety and Efficacy of Telaprevir in Combination With Peginterferon Alfa-2a and Ribavirin in Subjects Co-Infected With Hepatitis C Virus (HCV) and HIV
- Status
- COMPLETED
- Phase
- PHASE2
VX-950-TiDP24-C136 - A Trial to Evaluate the Effect of Telaprevir (TVR) on the Results of Electrocardiograms (Electric Recording of the Heart) in Healthy Volunteers
- Status
- COMPLETED
- Phase
- PHASE1
Drug-Drug Interaction Study of VX-809 and VX-770 in Healthy Subjects
- Status
- COMPLETED
- Phase
- PHASE1
Drug-Drug Interaction Study of VCH-222 and Telaprevir in Healthy Subjects
- Status
- COMPLETED
- Phase
- PHASE1
Study of Ivacaftor in Cystic Fibrosis Subjects Aged 12 Years and Older Homozygous for the F508del-CFTR Mutation
- Status
- TERMINATED
- Phase
- PHASE2
A Study to Investigate the Potential Interaction Between Telaprevir and Methadone, at Steady-State
- Status
- COMPLETED
- Phase
- PHASE1
A Phase I Trial of AVN944, an IMPDH Inhibitor, in Adults With Advanced Stage Solid Tumors
- Status
- WITHDRAWN
- Phase
- NA
Virology Follow up Study in Subjects Previously Treated With Telaprevir
- Status
- COMPLETED
- Phase
- N/A
Pharmacokinetics of Multiple Ascending Doses of VCH-222 in Subjects With Chronic Hepatitis C Infection
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Study of Ivacaftor in Cystic Fibrosis Subjects Aged 6 to 11 Years With the G551D Mutation
- Status
- COMPLETED
- Phase
- PHASE3
Study of Ivacaftor in Cystic Fibrosis Subjects Aged 12 Years and Older With the G551D Mutation
- Status
- COMPLETED
- Phase
- PHASE3
Intrahepatic HCV RNA and Telaprevir Kinetics in Hepatitis C Virus (HCV)
- Status
- COMPLETED
- Phase
- PHASE2
Study of VX-809 in Cystic Fibrosis Subjects With the ∆F508-CFTR Gene Mutation
- Status
- COMPLETED
- Phase
- PHASE2
Single and Multiple Dose Escalation Study of VX-509 in Healthy Subjects
- Status
- COMPLETED
- Phase
- PHASE1
Efficacy and Safety of MP-424, Peginterferon Alfa-2b and Ribavirin in Chronic Hepatitis C Who Have Not Achieved an Undetectable HCV RNA Level With Previous Interferon Based Therapy
- Status
- COMPLETED
- Phase
- PHASE3
Efficacy and Safety of MP-424, Peginterferon Alfa-2b, and Ribavirin in Patients With Chronic Hepatitis C Who Relapsed After Previous Interferon Based Therapy
- Status
- COMPLETED
- Phase
- PHASE3
Efficacy and Safety of MP-424/Peginterferon Alfa-2b/Ribavirin Combination in Treatment-Naïve Patients With Chronic Hepatitis C
- Status
- COMPLETED
- Phase
- PHASE3